NASDAQ · Medical - Instruments & Supplies

ANGO (ANGO) Stock

$14.63 +2.02% NASDAQ: ANGO Healthcare

Valuation

MetricValue
Price$14.63
Market Cap$604.69M
P/E Ratio-14.36
P/B Ratio2.69
P/S Ratio1.57
EPS (TTM)$0.00
52-Week High$15.11
52-Week Low$8.36
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-18.58%
ROA-12.14%
ROCE-21.86%
Gross Margin-13.70%
Operating Margin-13.70%
Net Margin-10.00%
Debt/Equity0.00
Current Ratio2.21

Annual Financials (USD)

Metric20212022202320242025
Revenue$291.0M$316.0M$339.0M$304.0M$292.0M
Operating Profit$-35.0M$-28.0M$-51.0M$-192.0M$-40.0M
Net Profit$-32.0M$-27.0M$-52.0M$-184.0M$-34.0M
EPS$-0.82$-0.68$-1.33$-4.59$-0.83
Op Margin-12.1%-9.0%-15.1%-63.3%-13.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$561.0M$553.0M$533.0M$318.0M$280.0M
Total Liabilities$122.0M$128.0M$154.0M$112.0M$97.0M
Cash$48.0M$29.0M$45.0M$76.0M$56.0M
Borrowings$20.0M$34.0M$65.0M$5.0M$0

Latest News

AngioDynamics Q4 Earnings Beat Estimates, Gross Margin Expands Zacks · Jul 15, 2026 AngioDynamics Inc (ANGO) Q4 2026 Earnings Call Highlights: Strong Revenue Growth Amidst Challenges GuruFocus.com · Jul 14, 2026 AngioDynamics Q4 Earnings Call Highlights MarketBeat · Jul 14, 2026 AngioDynamics (ANGO) Reports Q4 Loss, Beats Revenue Estimates Zacks · Jul 14, 2026 AngioDynamics Tops Revenue Forecasts and Raises Sales Outlook for Fiscal 2027 (ANGO) InvestorsHub · Jul 14, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$24.0M$-7.0M$0$-28.0M$-10.0M
Investing Cash Flow$-19.0M$-24.0M$-14.0M$118.0M$-15.0M
Financing Cash Flow$0$0$-1.0M$-15.0M$-6.0M
Net Cash Flow$-6.0M$-19.0M$16.0M$31.0M$-20.0M
Free Cash Flow$19.0M$-11.0M$-4.0M$-34.0M$-15.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield0.31%
Quick Ratio1.47
Interest Coverage—
Return 1Y45.93%
Return 3Y53.25%
Return 5Y-50.12%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CGEM $17.21 -1.49% -3.76 $1.06B 0.00%
FULC $3.73 +0.13% -5.17 $201.56M 0.00%
LAB $0.87 -3.27% -5.30 $339.79M 0.00%
NMRA $1.67 +3.42% -1.19 $308.50M 0.00%
OCGN $1.25 +1.63% -6.48 $423.15M 0.00%

About ANGO

ANGO is led by CEO James C. Clemmer, employs 748 people, headquartered in US, publicly traded since 2004.

ANGO stock trades at $14.63 with a market capitalization of $604.69M. The stock is valued at a price-to-earnings (P/E) ratio of -14.36, price-to-book of 2.69, price-to-sales of 1.57. Over the past 52 weeks the stock has ranged between $8.36 and $15.11, and currently trades 3.2% below its 52-week high.

On profitability, ANGO generates a return on equity (ROE) of -18.58%, return on capital employed of -21.86%, an operating margin of -13.70%, a net profit margin of -10.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides